Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • QE2
  • Advanced therapies
  • Virology
  • Bacteriology
  • Biotherapeutics
  • Analytical sciences
  • Infectious Disease Diagnostics
  • A to Z listing
  • Publications
  • Home  /  
  • Science and research  /  
  • Infectious Disease Diagnostics  /  
  • Centre for AIDS Reagents  /  
  • AIDS Reagents catalogue  /  
  • Product details

Product details

ID100108
TitlePBJ6
CharacteristicsPBJ6 is a derivative of PBJ5 in which the original SV40 early promoter fused to RU5 of HTLV-1 LTR was modified by removing the SV40 early promoter and retaining only HTLV-1 RU5. Ampicilin resistant.
SourceDr Massimo Pizzato
ReferencePizzato M. et. al. Nature, 526: 212-7
 
 
 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap